Article | March 15, 2019

5 Keys To Avoid Drug Development Delays When Using CDMOs

Source: Singota Solutions

By Ken Chomistek, Director of Quality Control and Development for the Laboratory, Singota Solutions

5 Keys To Avoid Drug Development Delays When Using CMOs

Dealing with contract development and manufacturing organizations (CDMOs) can be a nightmare for some drug developers. You may be a start-up pharmaceutical company with one molecule and you now need to hand over your baby to a cold and unfamiliar group of people who haven’t been nurturing this project for years. Maybe you are in academia and this is your first big chance to spin off your own company and you need a partner to help you with development. Whoever you are and whatever your situation; it can be daunting to select and partner with a CDMO. Here are five key factors to keep in mind when trying to troubleshoot drug development delays by selecting the right CDMO.